Zobrazeno 1 - 10
of 211
pro vyhledávání: '"E. A. Loeliger"'
Autor:
E A, Loeliger
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 138(27)
Autor:
E A, Loeliger
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 136(15)
Autor:
E. A. Loeliger
Publikováno v:
Annals of Hematology. 64:253-253
Publikováno v:
Thrombosis and Haemostasis. 40:272-287
SummaryStandardization of the thromboplastin most commonly used for anticoagulant control in The Netherlands has been achieved by the Dutch Reference Laboratory for Anticoagulant Control. The system established for control indicates the performance c
Autor:
L P van Halem-Visser, E A Loeliger, A. M. H. P. Van Den Besselaar, M Hoekstra-Schuman, W van der Marel-van Nieuwkoop
Publikováno v:
Thrombosis and Haemostasis. 43:053-057
SummaryThe modified (and thereby simplified) thromboplastin calibration procedure using pooled lyophilized normal and patient plasmas is shown to equal, for batch-to-batch control of Thrombotest, the calibration procedure described by Biggs and Denso
Publikováno v:
Thrombosis and Haemostasis. 39:210-214
SummaryA method is described for the preparation of blood samples differing in coagulability, now used for external quality control in The Netherlands by laboratories employing thrombotest for the assessment of oral anticoagulant agents.
Publikováno v:
Klinische Wochenschrift. 62:975-978
Protein C is a vitamin K-dependent protein which is produced in the liver. Activated protein C has an anticoagulant effect by inactivating the clotting factors V and VIII. We report on a young female patient who suffered from recurrent thrombosis of
Autor:
L P van Halem-Visser, E A Loeliger
Publikováno v:
Thrombosis and Haemostasis. 42:1115-1127
SummaryThe fourteen types of thromboplastin included in the ICTH/ICSH Collaborative Study on Prothrombin Time Standardization were investigated with respect to their sensitivity for factor VII, activation products, and PIVKAs. All of these thrombopla
Autor:
E A Loeliger
Publikováno v:
Thrombosis and Haemostasis. 42:1141-1152
SummaryFor patients on oral anticoagulation controlled with Quick’s prothrombin time test using rabbit brain thromboplastin American clinicians proposed in the early 1940s that the lower limit of prolongation be taken at 1.5 and the upper limit at